---
provider: perplexity
model: sonar-pro
cached: false
start_time: '2025-11-15T18:18:29.512838'
end_time: '2025-11-15T18:18:49.160449'
duration_seconds: 19.65
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    reasoning_effort: low
    search_domain_filter: []
    return_citations: true
    temperature: 0.0
citation_count: 9
---

## Question

Research the ARSB (ARSB) gene in human, focusing on its molecular function, biological processes, and cellular localization. Include information about protein domains, known interactions, and any disease associations.

## Output

The **ARSB (arylsulfatase B)** gene encodes a lysosomal enzyme essential for the degradation of specific glycosaminoglycans (GAGs), with broad implications for cellular metabolism, signaling, and human disease[1][2][3][6][8].

---

**Key Concepts and Definitions**

- **Molecular Function:**  
  ARSB encodes the enzyme **N-acetylgalactosamine-4-sulfatase**, which hydrolyzes (removes) 4-sulfate groups from the GAGs **dermatan sulfate** and **chondroitin-4-sulfate**[1][2][3][6][8]. This activity is classified as **sulfuric ester hydrolase activity** and is critical for the stepwise degradation of these GAGs in lysosomes[3][6][8].

- **Biological Processes:**  
  - **Lysosomal degradation of GAGs:** ARSB is central to the catabolism of dermatan sulfate and chondroitin sulfate, preventing their accumulation[1][2][3][6][8].
  - **Extracellular matrix remodeling:** ARSB influences the composition and turnover of the extracellular matrix, affecting cell adhesion, migration, and invasion[1][3][8].
  - **Cell signaling:** ARSB modulates signaling pathways, including those involving inflammatory mediators (e.g., interleukin-8), and impacts RhoA activation and matrix metalloproteinase secretion[1].
  - **Neuronal development:** In the central nervous system, ARSB regulates neurite outgrowth and neuronal plasticity by controlling sulfate GAG and neurocan levels[3][6][8].

- **Cellular Localization:**  
  - **Primary:** ARSB is predominantly a **lysosomal enzyme**[1][2][3][4][6][8].
  - **Extra-lysosomal:** Immunohistochemistry and immunofluorescence studies have also detected ARSB at the **cell membrane** of hepatocytes, sinusoidal endothelial cells, Kupffer cells, and the apical membranes of colonic and prostatic epithelial cells[4]. Membrane localization is reduced in malignant tissues[4].

---

**Protein Domains and Structure**

- **Protein Family:** ARSB belongs to the **sulfatase family**[1][3][6][8].
- **Domain Structure:**  
  - The enzyme is a **homodimer**[1][3].
  - Contains a **sulfatase domain** responsible for its catalytic activity[8].
  - The active site includes a **formylglycine** residue, essential for catalysis, generated by post-translational modification[6][8].
- **Isoforms:** Two alternatively spliced transcript variants encoding distinct isoforms have been identified[1][3].

---

**Known Interactions**

- **Protein-Protein Interactions:**  
  - ARSB interacts with **galectin-3**, influencing the expression of the proteoglycan **versican** via AP-1-mediated transcription[5].
  - Reduced ARSB activity increases galectin-3 binding to less-sulfated chondroitin-4-sulfate, affecting transcription factors (AP-1, SP-1) and downstream targets (e.g., WNT9A, GPNMB)[4][5].
  - ARSB deficiency leads to increased binding of **SHP2** to more-sulfated chondroitin-4-sulfate, activating signaling pathways (p38, MITF)[4].
- **Pathway Involvement:**  
  - ARSB is involved in **glycosaminoglycan metabolism** and **sphingolipid metabolism**[3].

---

**Disease Associations**

- **Mucopolysaccharidosis Type VI (MPS VI, Maroteaux–Lamy syndrome):**  
  - **Cause:** Autosomal recessive deficiency of ARSB leads to lysosomal accumulation of dermatan sulfate and chondroitin sulfate[1][2][3][4][6].
  - **Clinical Features:** Multi-system involvement, including skeletal, cardiac, and ocular abnormalities, organomegaly, and progressive tissue damage[1][2][3].
- **Cancer:**  
  - Reduced ARSB expression is linked to altered proteoglycan expression and tumor progression in prostate and colonic epithelial cells[1][4].
  - Acts as a **tumor suppressor**; silencing ARSB increases galectin-3 and promotes oncogenic signaling[4].
- **Cystic Fibrosis:**  
  - ARSB activity is modulated by the cystic fibrosis transmembrane conductance regulator (CFTR), with implications for disease pathology[4].
- **Atherosclerosis-related Stroke:**  
  - Emerging evidence suggests a role for ARSB in promoting atherosclerosis-related stroke, warranting further investigation[7].
- **Metachromatic Leukodystrophy:**  
  - ARSB is also associated with this lysosomal storage disorder, though less commonly than MPS VI[3].

---

**Recent Developments and Research (2023–2024)**

- **Therapeutic Approaches:**  
  - Enzyme replacement therapy (ERT) with recombinant ARSB is the standard treatment for MPS VI, aiming to reduce GAG accumulation and ameliorate symptoms[1].
  - Research is ongoing into gene therapy and small-molecule approaches to enhance ARSB activity or delivery, including targeting extra-lysosomal pools for tissue-specific effects[1].
- **Cancer and Metabolism:**  
  - Recent studies highlight ARSB’s role in tumor suppression and metabolic regulation, including effects on aerobic glycolysis and mitochondrial function in cancer cells[4].
- **Tissue Engineering:**  
  - ARSB is being explored for its potential to modify extracellular matrix composition and support tissue recovery after injury[1].

---

**Relevant Statistics and Data**

- **Functional Associations:**  
  - ARSB has over **6,400 functional associations** with biological entities across molecular, cellular, and disease categories, as extracted from 106 datasets[1].
- **Expression:**  
  - ARSB is expressed in multiple tissues, with highest levels in the **liver, pancreas, and kidneys**[4].

---

**Expert Opinions and Analysis**

- **Central Role in Lysosomal Homeostasis:**  
  - Experts emphasize ARSB’s indispensable function in lysosomal GAG degradation and its broader impact on cell signaling and tissue architecture[1][2][3][6][8].
- **Therapeutic Target:**  
  - ARSB is a validated target for enzyme replacement in MPS VI and is under investigation for broader applications in cancer and tissue engineering[1][4].

---

**Citations (with URLs and Dates where available):**

- [Ma’ayan Lab Harmonizome, ARSB gene](https://maayanlab.cloud/Harmonizome/gene/ARSB) (2024)
- [MedlinePlus Genetics, ARSB gene](https://medlineplus.gov/genetics/gene/arsb/) (2024)
- [GeneCards, ARSB](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ARSB) (2024)
- [Wikipedia, Arylsulfatase B](https://en.wikipedia.org/wiki/Arylsulfatase_B) (2024)
- [NCBI Gene, ARSB](https://www.ncbi.nlm.nih.gov/gene/411) (2024)
- [UniProt, ARSB_HUMAN (P15848)](https://www.uniprot.org/uniprotkb/P15848/entry) (2024)
- [NCBI Gene, ARSB](https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=411) (2024)
- [InterPro, Arylsulfatase B (P15848)](https://www.ebi.ac.uk/interpro/protein/reviewed/P15848) (2024)
- [Human Protein Atlas, ARSB](https://www.proteinatlas.org/ENSG00000113273-ARSB/structure+interaction) (2024)

## Citations

1. https://maayanlab.cloud/Harmonizome/gene/ARSB
2. https://medlineplus.gov/genetics/gene/arsb/
3. https://www.genecards.org/cgi-bin/carddisp.pl?gene=ARSB
4. https://en.wikipedia.org/wiki/Arylsulfatase_B
5. https://www.ncbi.nlm.nih.gov/gene/411
6. https://www.uniprot.org/uniprotkb/P15848/entry
7. https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=DetailsSearch&Term=411
8. https://www.ebi.ac.uk/interpro/protein/reviewed/P15848
9. https://www.proteinatlas.org/ENSG00000113273-ARSB/structure+interaction